Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Concert Pharmaceuticals, Inc.
3128
Concert Pharmaceuticals, Inc.
Health Care
Medical
Pharmaceuticals
Concert Pharmaceuticals is a biotechnology company utilizing deuterium todevelop novel medical candidates.
Suggest edits
Type
B2b
Founded
2006
Raised
$125.5M
Follow us
Companies in the same industry
Sanofi
BioDelivery Sciences International
Validic
Novan Therapeutics
Savara Pharmaceuticals
Ritter Pharmaceuticals, Inc.
Deciphera Pharmaceuticals
DoIt4YourDaughters
Cherrystone Angel Group
Avista Pharma
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
$30,000,000
Post-IPO debt - 2017
Hercules Capital, Inc.
$37,000,000
Venture capital (Series C) - 2008
Adage Capital Management
Flagship Ventures
Greylock Partners
+9
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
Pulse 2.0
Concert Pharmaceuticals (CNCE) Stock: Why The Price Surged Today
$30,000,000
Post-IPO debt
businesswire
,
PE HUB
Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital
$48,500,000
Venture capital (Series B)
Added by
via
PE Hub
Concert Pharma Raises $48.5 Million
